Cargando…

Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection

BACKGROUND: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. METHODS: All samples were collected from adults in the US w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wendel, Sarah K., Mullis, Caroline E., Eshleman, Susan H., Blankson, Joel N., Moore, Richard D., Keruly, Jeanne C., Brookmeyer, Ron, Quinn, Thomas C., Laeyendecker, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577851/
https://www.ncbi.nlm.nih.gov/pubmed/23437058
http://dx.doi.org/10.1371/journal.pone.0055525
_version_ 1782259988610154496
author Wendel, Sarah K.
Mullis, Caroline E.
Eshleman, Susan H.
Blankson, Joel N.
Moore, Richard D.
Keruly, Jeanne C.
Brookmeyer, Ron
Quinn, Thomas C.
Laeyendecker, Oliver
author_facet Wendel, Sarah K.
Mullis, Caroline E.
Eshleman, Susan H.
Blankson, Joel N.
Moore, Richard D.
Keruly, Jeanne C.
Brookmeyer, Ron
Quinn, Thomas C.
Laeyendecker, Oliver
author_sort Wendel, Sarah K.
collection PubMed
description BACKGROUND: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. METHODS: All samples were collected from adults in the US who were HIV infected for >2 years. Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures the proportion of IgG that is HIV-specific, and with an antibody avidity assay based on the Genetic Systems 1/2+ O ELISA. We tested 281 samples: (1) 30 samples from 18 patients with natural control of HIV-1 infection known as elite controllers or suppressors (2) 72 samples from 18 adults on antiretroviral therapy (ART), with 1 sample before and 2–6 samples after ART initiation, and (3) 179 samples from 20 virally-suppressed adults who had evidence of viral breakthrough receiving ART (>400 copies/ml HIV RNA) and with subsequent viral suppression. RESULTS: For elite suppressors, 10/18 had BED-CEIA values <0.8 normalized optical density units (OD-n) and these values did not change significantly over time. For patients receiving ART, 14/18 had BED-CEIA values that decreased over time, with a median decrease of 0.42 OD-n (range 0.10 to 0.63)/time point receiving ART. Three patterns of BED-CEIA values were observed during viral breakthrough: (1) values that increased then returned to pre-breakthrough values when viral suppression was re-established, (2) values that increased after viral breakthrough, and (3) values that did not change with viral breakthrough. CONCLUSIONS: Viral suppression and viral breakthrough were associated with changes in BED-CEIA values, reflecting changes in the proportion of HIV-specific IgG. These changes can result in misclassification of patients with long-term HIV infection as recently infected using the BED-CEIA, thereby influencing a falsely high value for cross-sectional incidence estimates.
format Online
Article
Text
id pubmed-3577851
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35778512013-02-22 Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection Wendel, Sarah K. Mullis, Caroline E. Eshleman, Susan H. Blankson, Joel N. Moore, Richard D. Keruly, Jeanne C. Brookmeyer, Ron Quinn, Thomas C. Laeyendecker, Oliver PLoS One Research Article BACKGROUND: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. METHODS: All samples were collected from adults in the US who were HIV infected for >2 years. Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures the proportion of IgG that is HIV-specific, and with an antibody avidity assay based on the Genetic Systems 1/2+ O ELISA. We tested 281 samples: (1) 30 samples from 18 patients with natural control of HIV-1 infection known as elite controllers or suppressors (2) 72 samples from 18 adults on antiretroviral therapy (ART), with 1 sample before and 2–6 samples after ART initiation, and (3) 179 samples from 20 virally-suppressed adults who had evidence of viral breakthrough receiving ART (>400 copies/ml HIV RNA) and with subsequent viral suppression. RESULTS: For elite suppressors, 10/18 had BED-CEIA values <0.8 normalized optical density units (OD-n) and these values did not change significantly over time. For patients receiving ART, 14/18 had BED-CEIA values that decreased over time, with a median decrease of 0.42 OD-n (range 0.10 to 0.63)/time point receiving ART. Three patterns of BED-CEIA values were observed during viral breakthrough: (1) values that increased then returned to pre-breakthrough values when viral suppression was re-established, (2) values that increased after viral breakthrough, and (3) values that did not change with viral breakthrough. CONCLUSIONS: Viral suppression and viral breakthrough were associated with changes in BED-CEIA values, reflecting changes in the proportion of HIV-specific IgG. These changes can result in misclassification of patients with long-term HIV infection as recently infected using the BED-CEIA, thereby influencing a falsely high value for cross-sectional incidence estimates. Public Library of Science 2013-02-20 /pmc/articles/PMC3577851/ /pubmed/23437058 http://dx.doi.org/10.1371/journal.pone.0055525 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Wendel, Sarah K.
Mullis, Caroline E.
Eshleman, Susan H.
Blankson, Joel N.
Moore, Richard D.
Keruly, Jeanne C.
Brookmeyer, Ron
Quinn, Thomas C.
Laeyendecker, Oliver
Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title_full Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title_fullStr Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title_full_unstemmed Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title_short Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
title_sort effect of natural and arv-induced viral suppression and viral breakthrough on anti-hiv antibody proportion and avidity in patients with hiv-1 subtype b infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577851/
https://www.ncbi.nlm.nih.gov/pubmed/23437058
http://dx.doi.org/10.1371/journal.pone.0055525
work_keys_str_mv AT wendelsarahk effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT mulliscarolinee effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT eshlemansusanh effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT blanksonjoeln effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT moorerichardd effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT kerulyjeannec effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT brookmeyerron effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT quinnthomasc effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection
AT laeyendeckeroliver effectofnaturalandarvinducedviralsuppressionandviralbreakthroughonantihivantibodyproportionandavidityinpatientswithhiv1subtypebinfection